The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis

Published:2023-08 Issue:8 Volume:22 Page:103335
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Wang Hongli,Lv Jiyang,He Juan,Wu Wenqi,Zhong Yuchao,Cao Siyang,Cai Yueming,Wang Qingwen

Funder

Shenzhen Municipal Health Commission

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference69 articles.

1. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study[J];Hamaguchi;Arch Dermatol,2011

2. Morbidity and mortality in adult polymyositis and dermatomyositis[J];Marie;Curr Rheumatol Rep,2012

3. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients[J];Marie;Arthritis Rheum,2011

4. Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and Meta-analysis[J];Zhang;PloS One,2016

5. Interstitial lung disease in polymyositis and dermatomyositis[J];Long;Clin Chest Med,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Gao et al.;Seminars in Arthritis and Rheumatism;2024-10

2. Interstitial lung disease and myositis;Current Opinion in Rheumatology;2024-08-13

3. Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study;Modern Rheumatology;2024-08-08

4. Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis;Seminars in Arthritis and Rheumatism;2024-08

5. Emergencies in inflammatory rheumatic diseases;Rheumatology International;2024-07-09